PORTLAND, Oregon, October 30, 2018 /PRNewswire/ -- Rise in consumption of antibiotics in low & middle-income countries (LMICs), heavy inflow of investments for R&D activities by biotech companies, and supportive rules & regulations would propel the growth of the global...
from PR Newswire: //https://ift.tt/2CNsEzk
No comments:
Post a Comment